0001628280-24-020789.txt : 20240506
0001628280-24-020789.hdr.sgml : 20240506
20240506181519
ACCESSION NUMBER: 0001628280-24-020789
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240502
FILED AS OF DATE: 20240506
DATE AS OF CHANGE: 20240506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Craig Jeffery Michael
CENTRAL INDEX KEY: 0001920469
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40537
FILM NUMBER: 24918943
MAIL ADDRESS:
STREET 1: C/O BRIGHT HEALTH GROUP INC
STREET 2: 8000 NORMAN CENTER DRIVE SUITE 1200
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55437
FORMER NAME:
FORMER CONFORMED NAME: Craig Jeff Michael
DATE OF NAME CHANGE: 20220330
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeueHealth, Inc.
CENTRAL INDEX KEY: 0001671284
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 474991296
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9250 NW 36TH STREET
STREET 2: SUITE 420
CITY: DORAL
STATE: FL
ZIP: 33178
BUSINESS PHONE: 612-238-1321
MAIL ADDRESS:
STREET 1: 9250 NW 36TH STREET
STREET 2: SUITE 420
CITY: DORAL
STATE: FL
ZIP: 33178
FORMER COMPANY:
FORMER CONFORMED NAME: Bright Health Group Inc.
DATE OF NAME CHANGE: 20210309
FORMER COMPANY:
FORMER CONFORMED NAME: Bright Health Inc.
DATE OF NAME CHANGE: 20160404
4
1
wk-form4_1715033709.xml
FORM 4
X0508
4
2024-05-02
0
0001671284
NeueHealth, Inc.
NEUE
0001920469
Craig Jeffery Michael
C/O NEUEHEALTH, INC.
8000 NORMAN CENTER DRIVE, SUITE 900
MINNEAPOLIS
MN
55437
0
1
0
0
GC & Corporate Secretary
0
Restricted Stock Units
2024-05-02
4
A
0
42000
0
A
Common Stock
42000
42000
D
Restricted Stock Units
2024-05-02
4
A
0
100000
0
A
Common Stock
100000
100000
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
This grant was approved on March 11, 2024 by the Issuer's Compensation and Human Capital Committee as part of the Issuer's annual equity grants, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2021 Omnibus Incentive Plan, which approval was obtained on May 2, 2024.
These restricted stock units vest in three equal annual installments beginning on March 11, 2025.
This grant was approved on October 11, 2023 by the Issuer's Compensation and Human Capital Committee, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2021 Omnibus Incentive Plan, which approval was obtained on May 2, 2024.
100% of these restricted stock units vest on October 11, 2026.
/s/Eric Halverson for Jeff Michael Craig, Attorney-in-Fact
2024-05-06